Premier Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-68,350
| Closed | -$7.67M | – | 180 |
|
|
2020
Q2 | $7.67M | Buy |
+68,350
| New | +$7.67M | 2.56% | 14 |
|
|
2019
Q4 | – | Sell |
-80,515
| Closed | -$7.89M | – | 138 |
|
|
2019
Q3 | $7.89M | Sell |
80,515
-7,695
| -9% | -$754K | 1.88% | 26 |
|
|
2019
Q2 | $11.6M | Sell |
88,210
-1,575
| -2% | -$206K | 2.72% | 17 |
|
|
2019
Q1 | $12.1M | Buy |
89,785
+73,860
| +464% | +$9.98M | 2.89% | 10 |
|
|
2018
Q4 | $1.55M | Sell |
15,925
-72,070
| -82% | -$7.01M | 0.42% | 43 |
|
|
2018
Q3 | $12.2M | Sell |
87,995
-1,580
| -2% | -$220K | 2.73% | 15 |
|
|
2018
Q2 | $11.1M | Buy |
89,575
+69,925
| +356% | +$8.68M | 2.62% | 18 |
|
|
2018
Q1 | $2.19M | Buy |
19,650
+9,145
| +87% | +$1.02M | 0.49% | 38 |
|
|
2017
Q4 | $1.26M | Sell |
10,505
-44,035
| -81% | -$5.26M | 0.28% | 57 |
|
|
2017
Q3 | $7.65M | Buy |
+54,540
| New | +$7.65M | 1.72% | 30 |
|
|
2016
Q4 | – | Sell |
-81,085
| Closed | -$9.94M | – | 110 |
|
|
2016
Q3 | $9.94M | Sell |
81,085
-3,335
| -4% | -$409K | 2.47% | 21 |
|
|
2016
Q2 | $9.86M | Buy |
84,420
+14,155
| +20% | +$1.65M | 2.54% | 20 |
|
|
2016
Q1 | $9.78M | Buy |
70,265
+360
| +0.5% | +$50.1K | 2.52% | 21 |
|
|
2015
Q4 | $13.3M | Sell |
69,905
-1,345
| -2% | -$257K | 3.32% | 12 |
|
|
2015
Q3 | $11.1M | Buy |
71,250
+405
| +0.6% | +$63.3K | 2.82% | 17 |
|
|
2015
Q2 | $12.8M | Buy |
70,845
+385
| +0.5% | +$69.6K | 3.02% | 15 |
|
|
2015
Q1 | $12.2M | Buy |
70,460
+1,710
| +2% | +$296K | 2.83% | 18 |
|
|
2014
Q4 | $12.7M | Buy |
68,750
+560
| +0.8% | +$104K | 3.11% | 14 |
|
|
2014
Q3 | $11.3M | Buy |
+68,190
| New | +$11.3M | 2.89% | 16 |
|